EKF Diagnostics (LON:EKF) Shares Cross Above 200-Day Moving Average of $28.40

EKF Diagnostics Holdings plc (LON:EKF) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 28.40 ($0.35) and traded as high as GBX 28.43 ($0.35). EKF Diagnostics shares last traded at GBX 27.25 ($0.34), with a volume of 102,579 shares.

EKF Diagnostics Stock Performance

The stock’s 50-day moving average is GBX 27.41 and its 200-day moving average is GBX 28.40. The stock has a market cap of £124.32 million, a price-to-earnings ratio of 2,740.00 and a beta of 0.58. The company has a current ratio of 2.69, a quick ratio of 1.77 and a debt-to-equity ratio of 6.01.

Insider Buying and Selling

In other news, insider Christopher H. B. Mills acquired 100,000 shares of the stock in a transaction on Friday, March 22nd. The stock was bought at an average price of GBX 26 ($0.32) per share, with a total value of £26,000 ($32,366.49). Corporate insiders own 5.11% of the company’s stock.

About EKF Diagnostics

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.